4.8 Article Retracted Publication

被撤回的出版物: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism (Retracted article. See vol. 152, pg. 367, 2013)

Journal

CELL
Volume 145, Issue 5, Pages 758-772

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2011.03.052

Keywords

-

Funding

  1. National Institute of Neurological Disorders and Stroke [5R01NS070301-02]
  2. National Institute of Mental Health [5P50MH084020-03]
  3. National 973 Basic Research Program of China [20009CB941400, R21HD065290, R01MH081164]
  4. Autism Speaks
  5. Autism Science Foundation
  6. Hartwell Foundation
  7. NIDCD

Ask authors/readers for more resources

We have created a mouse genetic model that mimics a human mutation of Shank3 that deletes the C terminus and is associated with autism. Expressed as a single copy [Shank3(+/Delta C) mice], Shank3 Delta C protein interacts with the wild-type (WT) gene product and results in >90% reduction of Shank3 at synapses. This gain-of-function phenotype is linked to increased polyubiquitination of WT Shank3 and its redistribution into proteasomes. Similarly, the NR1 subunit of the NMDA receptor is reduced at synapses with increased polyubiquitination. Assays of postsynaptic density proteins, spine morphology, and synapse number are unchanged in Shank3(+/Delta C) mice, but the amplitude of NMDAR responses is reduced together with reduced NMDAR-dependent LTP and LTD. Reciprocally, mGluR-dependent LTD is markedly enhanced. Shank3(+/Delta C) mice show behavioral deficits suggestive of autism and reduced NMDA receptor function. These studies reveal a mechanism distinct from haploinsufficiency by which mutations of Shank3 can evoke an autism-like disorder.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available